Product Program year 2024 Source: CMS Open Payments

Pts250

Device Proton Therapy for cancer treatment

Open in the dashboard

General payments

$336,693

394 payments

Research payments

$137,678

6 payments

Through program year 2024, $336,693 in general payments and $137,678 in research payments were reported against Pts250 (Proton Therapy for cancer treatment).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

10 rows
Year Kind Amount Payments
2024 General $31,452 71
2024 Research $42,263 1
2023 General $24,653 92
2023 Research $50,415 3
2022 General $76,978 71
2021 General $128,725 77
2021 Research $20,000 1
2020 General $19,541 16
2020 Research $25,000 1
2019 General $55,344 67

Breakdown

Who paid General payments · program years 2019–2024
  1. Mevion_Medical_Systems_Inc $336,693 394 payments
Top recipients General payments · program year 2024
  1. Nancy Tarbell Therapeutic Radiology · Boston, MA $6,170 20% · 3 payments
  2. Jeffrey Bradley Radiation Oncology · Saint Louis, MO $5,105 16% · 3 payments
  3. Billy Loo Radiation Oncology · Stanford, CA $4,940 16% · 6 payments
  4. Rahul Parikh Radiation Oncology · New York, NY $3,159 10% · 2 payments
  5. Barnes-Jewish Hospital Teaching hospital · MO $3,000 10% · 1 payment

The top 5 of 33 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Radiation Oncology Radiology $22,246 78% · 30 practitioners
  2. Therapeutic Radiology Radiology $6,170 22% · 1 practitioner
  3. Emergency Medicine $36 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2024
  1. Massachusetts $8,844 28% · 8 recipients
  2. Missouri $8,105 26% · 2 recipients
  3. California $4,940 16% · 1 recipient
  4. Pennsylvania $3,404 11% · 2 recipients
  5. New York $3,159 10% · 1 recipient

The top 5 of 16 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

394 general · 6 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record